ABMD - Abiomed Q2 2021 Earnings Preview
Abiomed (NASDAQ:ABMD) is scheduled to announce Q2 earnings results on Wednesday, October 28th, after market close.The consensus EPS Estimate is $0.97 (-5.8% Y/Y) and the consensus Revenue Estimate is $202.89M (-1.0% Y/Y).Estimated Expenses on a non-GAAP basis R&D $27.6M and SG&A $84.2M.Over the last 2 years, ABMD has beaten EPS estimates 100% of the time and has beaten revenue estimates 38% of the time.Over the last 3 months, EPS estimates have seen 3 upward revisions and 1 downward. Revenue estimates have seen 6 upward revisions and 0 downward.
For further details see:
Abiomed Q2 2021 Earnings Preview